HOME
PRODUCTS
COMPANY
CONTACT
FAQ
Research
Dictionary
Pharma
Sign Up
FREE
or
Login
Username:
Password:
Remember login
Login
Send password reminder...
Edward I Chang Selected Research
Edward I Chang Research Topics
Disease
12
Lymphedema (Milroy Disease)
03/2022 - 01/2017
12
Wounds and Injuries (Trauma)
03/2022 - 08/2007
12
Neoplasms (Cancer)
01/2021 - 02/2012
7
Hypoxia (Hypoxemia)
01/2010 - 01/2007
6
Breast Cancer Lymphedema
03/2022 - 02/2018
6
Breast Neoplasms (Breast Cancer)
03/2022 - 01/2017
5
Ischemia
05/2020 - 09/2005
4
Infections
06/2021 - 03/2016
3
Obesity
08/2022 - 06/2015
3
Hernia (Hernias)
01/2018 - 01/2011
3
Necrosis
01/2018 - 01/2008
3
Cellulitis
01/2017 - 08/2007
2
Hematoma
06/2021 - 01/2018
2
Head and Neck Neoplasms (Head and Neck Cancer)
03/2020 - 01/2018
2
Osteoradionecrosis
10/2018 - 02/2012
2
Thrombosis (Thrombus)
10/2018 - 10/2013
2
Seroma
09/2017 - 08/2007
2
Surgical Wound
05/2011 - 12/2009
2
Ulcer
01/2010 - 01/2008
1
Edema (Dropsy)
12/2021
1
Fistula
01/2021
1
Squamous Cell Carcinoma (Epidermoid Carcinoma)
03/2017
1
Osteomyelitis
03/2016
1
Peripheral Vascular Diseases (Peripheral Vascular Disease)
03/2016
1
Tracheoesophageal Fistula
11/2015
1
Parathyroid Neoplasms (Parathyroid Neoplasm)
11/2015
1
Laryngeal Neoplasms (Laryngeal Cancer)
11/2015
1
Esophageal Neoplasms (Esophageal Cancer)
11/2015
1
Non-Hodgkin Lymphoma (Lymphosarcoma)
11/2015
1
Fat Necrosis
06/2015
1
Inflammatory Breast Neoplasms
02/2015
1
Frostbite
06/2013
1
Hypertrophy
06/2012
1
Hyperplasia
08/2011
1
Foreign-Body Reaction
08/2011
1
Abscess
01/2011
1
Diabetic Foot
01/2010
1
Cicatrix (Scar)
12/2009
1
Hemorrhage
12/2009
1
Ventral Hernia
08/2007
1
Wound Infection (Wound Infections)
08/2007
1
Hemangioma (Angioma)
01/2007
Drug/Important Bio-Agent (IBA)
5
diclofenac hydroxyethylpyrrolidine (DIEP)
FDA Link
03/2022 - 12/2013
5
Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)
IBA
01/2010 - 01/2007
2
Plastics
IBA
07/2014 - 01/2011
2
Anti-Bacterial Agents (Antibiotics)
IBA
01/2011 - 08/2007
2
Deferoxamine (Desferal)
FDA Link
Generic
01/2010 - 12/2007
2
Transcription Factors (Transcription Factor)
IBA
01/2010 - 08/2009
2
Glucose (Dextrose)
FDA Link
Generic
01/2010 - 08/2009
2
Iron
IBA
01/2010 - 12/2007
2
Chelating Agents
IBA
01/2010 - 12/2007
2
Oxygen (Dioxygen)
IBA
01/2009 - 01/2008
2
Chemokines
IBA
01/2009 - 01/2007
2
Chemokine CXCL12
IBA
12/2007 - 01/2007
1
Collagen
IBA
12/2021
1
Dry Ice
IBA
06/2013
1
Antioxidants
IBA
01/2010
1
Streptozocin (Streptozotocin)
FDA Link
02/2009
1
Cytokines
IBA
02/2009
1
Luciferases
IBA
02/2009
1
Immunosorbents
IBA
02/2009
1
Proteins (Proteins, Gene)
FDA Link
02/2009
1
Interleukins
IBA
02/2009
1
Enzymes
IBA
02/2009
1
Interleukin-1beta (Interleukin 1 beta)
IBA
02/2009
1
CXCR4 Receptors (CXCR4 Receptor)
IBA
01/2009
1
Fibroblast Growth Factor 2 (Basic Fibroblast Growth Factor)
IBA
01/2008
1
Fibroblast Growth Factors (Fibroblast Growth Factor)
IBA
01/2008
1
Prolyl Hydroxylases (Prolyl Hydroxylase)
IBA
12/2007
1
erucylphosphocholine
IBA
12/2007
1
Hormones (Hormone)
IBA
01/2007
1
Estrogens (Estrogen)
FDA Link
01/2007
Therapy/Procedure
12
Free Tissue Flaps
01/2021 - 07/2014
12
Mammaplasty (Breast Reconstruction)
01/2021 - 06/2012
6
Drug Therapy (Chemotherapy)
03/2022 - 09/2015
5
Radiotherapy
03/2022 - 02/2012
5
Mastectomy (Mammectomy)
01/2021 - 06/2012
4
Therapeutics
03/2022 - 06/2013
4
Surgical Amputation (Amputations)
03/2016 - 01/2008
3
Perforator Flap
06/2021 - 01/2020
2
Operative Time
08/2022 - 05/2020
2
Surgical Instruments (Clip)
03/2022 - 12/2009
2
Laryngectomy
11/2020 - 11/2015
2
Operative Surgical Procedures
03/2020 - 02/2018
2
Segmental Mastectomy (Lumpectomy)
02/2015 - 06/2012
2
Electrosurgery
05/2011 - 12/2009
1
Postoperative Care
08/2022
1
Neck Dissection (Radical Neck Dissection)
10/2018
1
Breast Implants (Breast Implant)
10/2018
1
Contraindications
01/2018
1
Tissue Expansion
01/2018
1
Myocutaneous Flap
03/2017
1
Limb Salvage
03/2016
1
Patient Readmission
06/2012
1
Hemipelvectomy
05/2012
1
Sutures (Suture)
08/2011
1
Transplantation
12/2007
1
Abdominoplasty
08/2007
1
Distraction Osteogenesis
09/2005